SEC Form 4 · accession 0000904454-17-000567

ACHILLION PHARMACEUTICALS INC · ACHN

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Director

Period of report

Aug 10, 2017

Accepted (ET)

Aug 14, 2017 · 4:47 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001070336

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Aug 10, 2017	M	2,790,539	$3.1125	A	5,108,336	I	By Domain Partners VIII, L.P.
Common Stock^F1	Aug 10, 2017	F	1,714,954	$5.06	D	3,393,382	I	By Domain Partners VIII, L.P.
Common Stock^F1	Aug 10, 2017	M	20,706	$3.1125	A	37,885	I	By DP VIII Associates, L.P.
Common Stock^F1	Aug 10, 2017	F	12,726	$5.06	D	25,159	I	By DP VIII Associates, L.P.
Common Stock^F1	holding	—	—		—	25,000	I	By Domain Associates, LLC
Common Stock	holding	—	—		—	31,431	D

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Warrants to Purchase Common Stock^F1	$3.1125	Aug 10, 2017	M	2,790,539	D	Aug 20, 2010	Aug 20, 2017	Common Stock	2,790,539	0	I
Warrants to Purchase Common Stock^F1	$3.1125	Aug 10, 2017	M	20,706	D	Aug 20, 2010	Aug 20, 2017	Common Stock	20,706	0	I

F1The Reporting Person is a Managing Member of Domain Associates, LLC and a Managing Member of One Palmer Square Associates VIII, LLC, which is the sole general partner of Domain Partners VIII, L.P. and DP VIII Associates, L.P. Pursuant to Instruction 4(b)(iv) of Form 4, the Reporting Person has elected to report as indirectly beneficially owned the entire number of securities beneficially owned by each such entity. The Reporting Person disclaims beneficial ownership of any securities, and any proceeds thereof, that exceed her pecuniary interest therein and/or that are not actually distributed to her.